Subject(s)
Antidepressive Agents, Tricyclic/therapeutic use , Circadian Rhythm/physiology , Depression/drug therapy , Heart Rate/physiology , Myocardial Ischemia/physiopathology , Thiazepines/therapeutic use , Adult , Aged , Depression/complications , Depression/physiopathology , Electrocardiography, Ambulatory , Female , Follow-Up Studies , Heart Rate/drug effects , Humans , Male , Middle Aged , Myocardial Ischemia/complications , Myocardial Ischemia/drug therapy , Treatment OutcomeABSTRACT
AIM: To study heart rate variability (HRV) according to 24-h Holter monitoring of ECG in patients with ischemic heart disease (IHD) and to examine effects of tianeptine on HRV. MATERIAL AND METHODS: Twenty eight patients with IHD (17 males and 11 females aged 40-70 years) with a verified IHD diagnosis and atherosclerosis of the coronary arteries participated in the trial. Severity of depressive syndrome was assessed by CES-D questionnaire. HR V was assessed by weighted mean variation of the rhythmogram (WMVR) for 24 hours. RESULTS: Initial WMVR (m +/- sigma) in the study group (IHD with depression, n = 15) was 670 +/- 260 ms, in the control group (IHD without depression, n = 13) - 625 +/- 191 ms (the difference was insignificant (p = 0.72). Initial (m +/- sigma) WMVR in men of the study group (n = 6) before therapy was 460 +/- 139 ms that was less than in the control group (633 +/- 183 ms, n = 11). CONCLUSION: In men HRV depends on duration of the disease. There was a negative correlation between WMVR difference before and after treatment with tianeptine and difference of relevant depression indices with high correlation coefficient (-0.74, p = 0.03).
